Subscribe
shutterstock_1764329549_ben_photo
Ben Photo / Shutterstock.com
23 June 2021BiotechnologyThe C5 Group (American Conference Institute, The Canadian Institute, C5)

Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank

The C5 Group—which constitutes the ACI, The Canadian Institute and C5—invites WIPR readers to the conference on July 27-28, 2021, to find out exactly how these new  developments will impact their practice and clients.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
‘Breaking’ patents would harm innovation: think tank
5 March 2019   The Information Technology and Innovation Foundation think tank has called on the US National Institutions of Health to maintain IP protection amid calls to “break” patents in order to lower drug prices.
Americas
Biosimilar boom could save billions, think tank claims
25 October 2017   Introducing more biosimilars could cut healthcare spending by $54 billion over the next ten years, a figure far higher than initially thought, a think tank and research organisation has claimed.


Editor's picks

Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025

Editor's picks

Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
29 August 2025
Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Killing the golden goose of US drug innovation (Part I): Follow the money
Roche resolves cancer test dispute with Stanford affiliated startup
An update on patenting in Ukraine, Russia and Eurasia
The rise of pro-NPE and patent sentiment in the US
Why the Caribbean cannabis economy is ripe for IP protection
China filings push rise in patent applications in Ireland
Brain disorder medtech rivals butt heads at ITC